Healthtech funding in November 2022
European Healthtech startup funding raised during November 2022.
In November 2022, 60 European Healthtech companies closed 62 funding rounds and raised €607M in equity funding (excluding debt and grants), down 41.3% versus November 2021. Debt rounds added €118M. UK led by capital raised, and APY Ventures was the most active investor. Data as of 20 Nov 2026.
Equity funding
€607M
-41.3% vs November 2021 · excl. debt & grants · +€118M debt
Funding rounds
62
+1.6% vs November 2021
Companies
60
Top country
UK
Rank among sectors
#3
10.5% of sector funding
Debt financing
€118M
16.2% of total
Top-10 round share
72.2%
of disclosed capital
Rounds ≥ €100M
2
Top countries
by € raisedHealthtech — top countries by capital, November 2022 — interactive chart.
Data table
| Healthtech — top countries by capital, November 2022 | |
|---|---|
| UK | €331M |
| Denmark | €119M |
| Germany | €112M |
| Switzerland | €51M |
| Belgium | €44M |
| Netherlands | €21M |
| Hungary | €20M |
| Spain | €19M |
Stage mix
by € raisedHealthtech — stage mix, November 2022 — interactive chart.
Data table
| Healthtech — stage mix, November 2022 | |
|---|---|
| Other | €221M |
| Series A | €149M |
| Series C | €135M |
| Debt | €118M |
| Series B | €65M |
| Seed | €30M |
| Pre-Seed | €4.2M |
| Grant | €3.5M |
| Crowdfunding | €3.0M |
Exits & M&A
9 Acquisition9 exits · €2.6B disclosed.
| Immucor | Acquisition | Nov 2022 | €2.0B |
| Neogene Therapeutics | Acquisition | Nov 2022 | €310M |
| Focus-X Therapeutics | Acquisition | Nov 2022 | €237M |
| BModesto | Acquisition | Nov 2022 | €75M |
Top deals
largest disclosed rounds in November 2022| Company | Stage | Date | Amount |
|---|---|---|---|
| TauRx Pharmaceuticals | Other | Nov 2022 | €115M |
| Demant AS | Debt | Nov 2022 | €115M |
| Osler Diagnostics | Series C | Nov 2022 | €85M |
| CatalYm | Series C | Nov 2022 | €50M |
| Novadip Biosciences | Series B | Nov 2022 | €40M |
| Opna Bio | Series A | Nov 2022 | €37M |
| Temedica | Series B | Nov 2022 | €25M |
| Eagle Genomics | Other | Nov 2022 | €20M |
| Turbine | Series A | Nov 2022 | €20M |
| Accession Therapeutics | Other | Nov 2022 | €19M |
| NRG Therapeutics | Series A | Nov 2022 | €18M |
| Healios | Other | Nov 2022 | €16M |
| Enzyre | Series A | Nov 2022 | €12M |
| Re-Vana Therapeutics | Series A | Nov 2022 | €11M |
| Qunomedical | Series A | Nov 2022 | €10M |
Top investors
most active in November 2022, by deal count- APY Ventures2 deals
- Bertelsmann Investments2 deals
- BioGeneration Ventures2 deals
- Brandon Capital2 deals
- Calm Storm Ventures2 deals
- Capital Cell2 deals
- Co-Fund NI2 deals
- High-Tech Gründerfonds (HTGF)2 deals
- Innovate UK2 deals
- Inveready2 deals